Picture EBD Group Bio-Europe Spring 2023 Basel 650x150px
Employment/Membership › Details

Biohit–Hahtela J: management, 202209– CEO joined as CFO 202106 before Nordea


Period Period 2022-09-02
Organisation Organisation Biohit Oyj
  Group Biohit (Group)
Products Product BIOTECH
  Product 2 finance
Persons Person Hahtela, Jussi (Biohit 202209– CEO joined as CFO 202106 before Nordea)
  Person 2 Siltala, Päivi (Biohit –202209 CEO RESIGNED 9/22)

Biohit Oyj. (9/2/22). "Press Release: Change of CEO at Biohit Oyj".

CEO Päivi Siltala has resigned. The Board of Directors of Biohit Oyj has appointed CFO Jussi Hahtela the new CEO. Hahtela will start in the new role immediately.

Chairperson of the Board of Directors, PhD Lea Paloheimo: “Hahtela has as the CFO had an important role in business development and improved profitability. The Board of Directors believe that CEO change will strengthen the positive development further.”

Master of Social Sciences Jussi Hahtela (b. 1973) has worked at Biohit as CFO from June 2021. He has previously worked in Nordea for example as chief strategist and Head of FX sales Finland.

Additional information:

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.

Record changed: 2022-09-02


Picture EBD Group Bio-Europe Spring 2023 Basel 560x80px

More documents for Biohit (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Bio-Europe Spring 2023 Basel 650x300px

» top